Unicycive Therapeutics, Inc. (UNCY)
5.18
-0.08
(-1.61%)
USD |
NASDAQ |
Aug 31, 11:49
Unicycive Therapeutics Free Cash Flow : -27.85M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.85M |
| March 31, 2026 | -28.67M |
| December 31, 2025 | -31.34M |
| September 30, 2025 | -29.88M |
| June 30, 2025 | -33.19M |
| March 31, 2025 | -31.10M |
| December 31, 2024 | -28.65M |
| September 30, 2024 | -26.52M |
| June 30, 2024 | -21.66M |
| March 31, 2024 | -20.84M |
| December 31, 2023 | -18.30M |
| September 30, 2023 | -19.94M |
| Date | Value |
|---|---|
| June 30, 2023 | -19.08M |
| March 31, 2023 | -16.61M |
| December 31, 2022 | -15.65M |
| September 30, 2022 | -11.00M |
| June 30, 2022 | -10.91M |
| March 31, 2022 | -8.082M |
| December 31, 2021 | -5.796M |
| September 30, 2021 | -4.902M |
| June 30, 2021 | -2.134M |
| March 31, 2021 | -2.059M |
| December 31, 2020 | -1.459M |
| September 30, 2020 | -1.37M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Theriva Biologics, Inc. | -12.76M |
| AbbVie, Inc. | 18.21B |
| Decoy Therapeutics, Inc. | -8.367M |
| Nkarta, Inc. | -93.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.604M |
| Cash from Investing (Quarterly) | -0.023M |
| Cash from Financing (Quarterly) | 14.44M |
| Free Cash Flow Per Share (Quarterly) | -0.2825 |
| Free Cash Flow to Equity (Quarterly) | -7.40M |
| Free Cash Flow to Firm (Quarterly) | -7.603M |
| Free Cash Flow Yield | -23.63% |